0KCS.LSE OPKO Health, Inc.

Healthcare Diagnostics & Research London Exchange
- USD
Market cap
-
P/E
-
P/B
-
ROE
-10.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0KCS.LSE undervalued?

Graham number

The Graham number of OPKO Health, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

OPKO Health, Inc. fundamental analysis

No fundamental analysis for OPKO Health, Inc. yet.

OPKO Health, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About OPKO Health, Inc.

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecifi…

Full company profile